This review summarizes current empiric management strategies for neonatal coagulation disorders and thromboembolism, emphasizing the urgent need for randomized clinical trials to establish safe and effective evidence-based guidelines for this vulnerable population.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chang Won Choi (2011) conducted a review in Neonatal coagulation disorders and thromboembolism. Anticoagulation therapy, thrombolytic therapy, and blood products was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: